Pharmacology, Toxicology and Pharmaceutical Science
Liposome
100%
Neoplasm
81%
Triple Negative Breast Cancer
66%
Topotecan
33%
Hyperthermia
33%
Controlled Drug Release
33%
Carboplatin
33%
Drug Release
27%
Gadolinium
18%
Nanocarrier
11%
Doxorubicin
10%
Anticancer Drug
8%
Irinotecan
8%
Therapeutic Window
8%
Active Metabolite
8%
Malignant Neoplasm
7%
Biochemistry, Genetics and Molecular Biology
Lipid
44%
Controlled Drug Release
33%
FUS
33%
Gadolinium
33%
Antineoplastic Activity
33%
Magnetic Resonance Imaging
33%
Infrared Radiation
27%
Contrast Enhancement
22%
Lipid Bilayer
22%
Anticancer
22%
Metabolite
16%
Heat Sensitivity
16%
Doxorubicin
16%
Single Drug Dose
16%
Mouse Model
5%
Drug Therapy
5%
Contrast Medium
5%
Tumor Progression
5%
Growth Inhibition
5%
Medicine and Dentistry
Liposome
66%
Neoplasm
56%
Controlled Drug Release
33%
Triple Negative Breast Cancer
33%
Hyperthermia
33%
Topotecan
33%
High-Intensity Focused Ultrasound
14%
Magnetic Resonance Imaging
14%
Heat Therapy
11%
Gadolinium
10%
Doxorubicin
10%
